Insmed (INSM) Prepaid Assets (2010 - 2026)
Insmed (INSM) recorded quarterly Prepaid Assets of $78.2 million in Q1 2026, down 14.29% quarter-over-quarter from $91.2 million in Q4 2025, and up 42.74% on a YoY basis from $54.8 million in Q1 2025.
Insmed (INSM) Prepaid Assets (2010 - 2026) Analysis & Trends
Insmed's Prepaid Assets history runs 17 years deep, the most recent figure standing at $78.2 million for Q1 2026.
- In Q1 2026, Prepaid Assets rose 42.74% year-over-year to $78.2 million; the TTM figure through Mar 2026 stood at $78.2 million (up 42.74% YoY), while the FY2025 annual figure was $91.2 million, up 144.96% from the prior year.
- Prepaid Assets was $78.2 million for Q1 2026 at Insmed, down from $91.2 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $91.2 million in Q4 2025 to a low of $23.4 million in Q2 2022.
- Historically, Prepaid Assets has averaged $42.7 million across 5 years, with a median of $37.2 million in 2024.
- The sharpest annual moves came in 2022 and 2025: Prepaid Assets retreated 24.81% in 2022, then jumped 144.96% in 2025.
- A 5-year view of Prepaid Assets shows it stood at $25.5 million in 2022, then decreased by 5.06% to $24.2 million in 2023, then jumped by 54.04% to $37.2 million in 2024, then surged by 144.96% to $91.2 million in 2025, then declined by 14.29% to $78.2 million in 2026.
- The last three Prepaid Assets figures came in at $78.2 million (Q1 2026), $91.2 million (Q4 2025), and $65.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Insmed | 19.79 Bn | 18.57 Bn | 258.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 78.20 Mn |
| Dec 31, 2025 | 91.24 Mn |
| Sep 30, 2025 | 65.60 Mn |
| Jun 30, 2025 | 62.18 Mn |
| Mar 31, 2025 | 54.78 Mn |
| Dec 31, 2024 | 37.25 Mn |
| Sep 30, 2024 | 41.15 Mn |
| Jun 30, 2024 | 41.02 Mn |
| Mar 31, 2024 | 42.87 Mn |
| Dec 31, 2023 | 24.18 Mn |
| Sep 30, 2023 | 27.12 Mn |
| Jun 30, 2023 | 26.36 Mn |
| Mar 31, 2023 | 28.54 Mn |
| Dec 31, 2022 | 25.47 Mn |
| Sep 30, 2022 | 25.19 Mn |
| Jun 30, 2022 | 23.36 Mn |
| Mar 31, 2022 | 31.15 Mn |
| Dec 31, 2021 | 28.90 Mn |
| Sep 30, 2021 | 25.66 Mn |
| Jun 30, 2021 | 31.07 Mn |